Khaled Z Sheir Selected Research

Lithotripsy (Extracorporeal Shockwave Lithotripsy)

1/2021	The alternating bidirectional versus the standard approach during shock wave lithotripsy for upper lumbar ureteric stones: a randomized controlled trial.
1/2020	Optimal non-invasive treatment of 1-2.5 cm radiolucent renal stones: oral dissolution therapy, shock wave lithotripsy or combined treatment-a randomized controlled trial.
5/2019	Shock wave lithotripsy versus endoscopic cystolitholapaxy in the management of patients presenting with calcular acute urinary retention: a randomised controlled trial.
1/2019	Efficacy of pethidine, ketorolac, and lidocaine gel as analgesics for pain control in shockwave lithotripsy: A single-blinded randomized controlled trial.
6/2018	Hospital admission for treatment of complications after extracorporeal shock wave lithotripsy for renal stones: a study of risk factors.
6/2016	Does lithotripsy increase stone recurrence? A comparative study between extracorporeal shockwave lithotripsy and non-fragmenting percutaneous nephrolithotomy.
9/2015	Clinically Insignificant Residual Fragments: Is It an Appropriate Term in Children?
4/2015	Risk factors for formation of steinstrasse after extracorporeal shock wave lithotripsy for pediatric renal calculi: a multivariate analysis model.
12/2014	Evaluation of acute post-shock wave lithotripsy renal changes by dynamic magnetic resonance imaging: a prospective clinical study.
12/2013	Extracorporeal shockwave lithotripsy for renal stones in pediatric patients: a multivariate analysis model for estimating the stone-free probability.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Khaled Z Sheir Research Topics

Disease

31	Shock 01/2021 - 03/2002
6	Calculi (Calculus) 06/2016 - 07/2003
5	Kidney Calculi (Kidney Stone) 04/2015 - 01/2004
3	Ureteral Calculi 06/2009 - 11/2006
3	Hydronephrosis 03/2007 - 11/2006
2	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 01/2021 - 01/2005
2	Pain (Aches) 01/2019 - 11/2006
2	Hypertension (High Blood Pressure) 12/2014 - 06/2008
2	Urinary Calculi (Urinary Calculus) 02/2011 - 12/2003
2	Neoplasms (Cancer) 08/2005 - 01/2005
2	Hemorrhage 02/2005 - 11/2003
1	Lower Urinary Tract Symptoms 01/2021
1	Urinary Tract Infections (Urinary Tract Infection) 01/2021
1	Hypoxia (Hypoxemia) 01/2021
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2021
1	Necrosis 01/2021
1	Urinary Retention 05/2019
1	Urinary Incontinence 01/2019
1	Overactive Urinary Bladder (Overactive Bladder) 01/2019
1	Albuminuria 01/2017
1	Diabetes Mellitus 12/2014
1	Hematoma 12/2014
1	Solitary Kidney 06/2008
1	Dysuria 11/2006
1	Hematuria 11/2006
1	Pyuria 11/2006
1	Staghorn Calculi 01/2006
1	Lithiasis 09/2005

Drug/Important Bio-Agent (IBA)

2	StruviteIBA 02/2011 - 05/2005
2	Calcium OxalateIBA 02/2011 - 05/2005
2	Uric Acid (Urate)IBA 02/2011 - 05/2005
2	CreatinineIBA 06/2008 - 02/2005
1	Pharmaceutical PreparationsIBA 01/2021
1	InterleukinsIBA 01/2021
1	Epirubicin (Ellence)FDA LinkGeneric 01/2021
1	AntigensIBA 01/2021
1	incobotulinumtoxinA FDA Link 01/2019
1	Analgesics (Analgesic Drugs)IBA 01/2019
1	Opioid Analgesics (Opioids)IBA 01/2019
1	Lidocaine (Xylocaine)FDA LinkGeneric 01/2019
1	Meperidine (Pethidine)FDA LinkGeneric 01/2019
1	Type A Botulinum Toxins (Botox)FDA Link 01/2019
1	KetorolacIBA 01/2019
1	Losartan (Cozaar)FDA LinkGeneric 01/2017
1	Lipocalin-2IBA 01/2017
1	Contrast MediaIBA 08/2005
1	Hydroxyl RadicalIBA 05/2005
1	ApatitesIBA 05/2005
1	Radio-Opaque acrylic resinIBA 02/2005
1	Prothrombin (Factor II)IBA 02/2005
1	6H,8H- 3,4- dihydropyrimido(4,5- c)(1,2)oxazin- 7- oneIBA 01/2005
1	Fluconazole (Zonal)FDA LinkGeneric 01/2005
1	Prostate-Specific Antigen (Semenogelase)IBA 01/2005
1	anhydrous dibasic calcium phosphate (calcium hydrogen phosphate)IBA 12/2003
1	Cysteine (L-Cysteine)FDA Link 12/2003
1	Calcium Sulfate (Alabaster)IBA 12/2003
1	A-factor (Streptomyces)IBA 12/2003
1	dihydrate dibasic calcium phosphate (brushite)IBA 12/2003
1	Cystine (L-Cystine)IBA 12/2003

Therapy/Procedure

34	Lithotripsy (Extracorporeal Shockwave Lithotripsy) 01/2021 - 03/2002
5	Therapeutics 01/2020 - 03/2002
4	Percutaneous Nephrolithotomy 06/2016 - 08/2006
2	Aftercare (After-Treatment) 12/2014 - 06/2008
2	Contraindications 12/2014 - 08/2003
1	Extracorporeal Shockwave Therapy 01/2021
1	Analgesia 01/2019
1	Retreatment 09/2012
1	Operative Surgical Procedures 02/2011
1	Stents 11/2006
1	Urinary Diversion (Ileal Conduit) 09/2005
1	Cystectomy 09/2005